GlassScriptPhysician profile
Sandra P Garcia
NPI 1992707665
$6,490.23
in general payments reported to CMS, 2019-2025
25 companies · $1,025 in 2025
The $1,025 reported for 2025 was more than what 86% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $352 · 2021: $284 · 2022: $2,246 · 2023: $1,290 · 2024: $687 · 2025: $1,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,002.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,558.31 | 2022 | |
| Tactile Systems Technology INC | $1,024.95 | 2020-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Paratek Pharmaceuticals, INC. | $933.04 | 2023-2025 | Nuzyra |
| Horizon Therapeutics Plc | $768.64 | 2020-2023 | Krystexxa |
| Smith+Nephew, INC. | $501.54 | 2019-2022 | |
| Nevro Corp. | $172.86 | 2022-2023 | Senza |
| Musculoskeletal Transplant Foundation INC. | $169.78 | 2022 | |
| Aroa Biosurgery Incorporated | $153.21 | 2020 | |
| Amgen INC. | $148.93 | 2021-2025 | Krystexxa |
| Averitas Pharma INC. | $143.73 | 2023-2025 | Qutenza |
| Leo Pharma INC. | $125.04 | 2023 | Adbry |
| Organogenesis INC. | $125.00 | 2021 | |
| Ibsa Pharma INC. | $125.00 | 2023 | Licart |
| Wright Medical Technology, INC. | $97.89 | 2019 | |
| Medtronic Vascular, INC. | $86.31 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $53.77 | 2023-2024 | |
| Bioventus LLC | $47.87 | 2025 | Exogen Ultrasound Bone Healing System |
| Incyte Corporation | $47.86 | 2025 | Opzelura |
| Kerecis Limited | $46.89 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Orthofix Medical, INC. | $41.63 | 2023-2024 | Physio-Stim |
| Shield Therapeutics INC | $39.91 | 2024-2025 | |
| Exact Sciences Corporation | $25.04 | 2025 | Cologuard Collection Kit |
| Abbvie INC. | $22.00 | 2023 | |
| Collaborative Care Diagnostics, LLC | $18.69 | 2022 | |
| Advanced Oxygen Therapy INC. | $12.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.